FI970095A0 - Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena - Google Patents
Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineenaInfo
- Publication number
- FI970095A0 FI970095A0 FI970095A FI970095A FI970095A0 FI 970095 A0 FI970095 A0 FI 970095A0 FI 970095 A FI970095 A FI 970095A FI 970095 A FI970095 A FI 970095A FI 970095 A0 FI970095 A0 FI 970095A0
- Authority
- FI
- Finland
- Prior art keywords
- drugs
- preparation
- chemical compounds
- new chemical
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4424714A DE4424714A1 (de) | 1994-07-13 | 1994-07-13 | Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff |
PCT/EP1995/002113 WO1996002496A1 (fr) | 1994-07-13 | 1995-06-03 | Nouveau compose chimique, sa preparation et son utilisation en tant que medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970095A0 true FI970095A0 (fi) | 1997-01-10 |
FI970095A FI970095A (fi) | 1997-01-10 |
Family
ID=6523048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970095A FI970095A (fi) | 1994-07-13 | 1997-01-10 | Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena |
Country Status (25)
Country | Link |
---|---|
US (1) | US5686496A (fr) |
EP (1) | EP0770058A1 (fr) |
JP (1) | JPH10502646A (fr) |
KR (1) | KR970704674A (fr) |
CN (1) | CN1152303A (fr) |
AU (1) | AU2736895A (fr) |
BG (1) | BG101104A (fr) |
BR (1) | BR9508395A (fr) |
CA (1) | CA2194886A1 (fr) |
CO (1) | CO4410185A1 (fr) |
CZ (1) | CZ8297A3 (fr) |
DE (1) | DE4424714A1 (fr) |
EE (1) | EE9700065A (fr) |
FI (1) | FI970095A (fr) |
HR (1) | HRP950363A2 (fr) |
HU (1) | HUT76827A (fr) |
IL (1) | IL114572A0 (fr) |
MX (1) | MX9700245A (fr) |
NO (1) | NO970123L (fr) |
PE (1) | PE35196A1 (fr) |
PL (1) | PL318114A1 (fr) |
SK (1) | SK1897A3 (fr) |
WO (1) | WO1996002496A1 (fr) |
YU (1) | YU45395A (fr) |
ZA (1) | ZA955781B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6486181B1 (en) | 1992-08-28 | 2002-11-26 | City Of Hope | Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states |
US6191169B1 (en) | 1992-08-28 | 2001-02-20 | City Of Hope | Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
AU5857296A (en) * | 1995-05-17 | 1996-11-29 | Eli Lilly And Company | Use of leukotriene antagonists for alzheimer's disease |
DE19546452A1 (de) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel |
DE19636689A1 (de) * | 1996-09-10 | 1998-03-12 | Boehringer Ingelheim Kg | Neue Benzamidinderivate |
DE19718334A1 (de) * | 1997-04-30 | 1998-11-05 | Boehringer Ingelheim Pharma | Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
ID24720A (id) | 1997-12-12 | 2000-08-03 | Novartis Ag | Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis |
DE19834713A1 (de) * | 1998-07-31 | 2000-02-03 | Boehringer Ingelheim Pharma | Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US6528491B2 (en) * | 2000-10-24 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Pyranoside derivatives |
JP2004523512A (ja) * | 2001-01-16 | 2004-08-05 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | ムチン遺伝子の増大された発現により生じる疾患の治療及び/又は予防のためのltb4アンタゴニストの使用 |
BR0212078A (pt) * | 2001-08-31 | 2004-09-28 | Neurochem Int Ltd | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto |
US20070105104A1 (en) * | 2003-05-06 | 2007-05-10 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4) |
US7262223B2 (en) * | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
WO2006004370A1 (fr) * | 2004-07-05 | 2006-01-12 | Dong Wha Pharmaceutical. Ind. Co., Ltd. | Composition pour la prevention et le traitement de maladies inflammatoires allergiques |
EP1997491B1 (fr) * | 2004-07-14 | 2010-09-22 | Inflammation Research Center Company Ltd. | Procédé d'inhibition d'une métastase de tumeur |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0518818A3 (en) * | 1991-06-11 | 1993-04-28 | Ciba-Geigy Ag | Arylethers, their manufacture and use as medicament |
ES2165122T3 (es) * | 1992-02-05 | 2002-03-01 | Boehringer Ingelheim Pharma | Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4. |
-
1994
- 1994-07-13 DE DE4424714A patent/DE4424714A1/de not_active Withdrawn
-
1995
- 1995-06-03 JP JP8504619A patent/JPH10502646A/ja active Pending
- 1995-06-03 CA CA002194886A patent/CA2194886A1/fr not_active Abandoned
- 1995-06-03 WO PCT/EP1995/002113 patent/WO1996002496A1/fr not_active Application Discontinuation
- 1995-06-03 MX MX9700245A patent/MX9700245A/es unknown
- 1995-06-03 BR BR9508395A patent/BR9508395A/pt unknown
- 1995-06-03 SK SK18-97A patent/SK1897A3/sk unknown
- 1995-06-03 EE EE9700065A patent/EE9700065A/xx unknown
- 1995-06-03 CN CN95194047A patent/CN1152303A/zh active Pending
- 1995-06-03 EP EP95922492A patent/EP0770058A1/fr not_active Withdrawn
- 1995-06-03 PL PL95318114A patent/PL318114A1/xx unknown
- 1995-06-03 KR KR1019970700123A patent/KR970704674A/ko not_active Application Discontinuation
- 1995-06-03 US US08/765,527 patent/US5686496A/en not_active Expired - Fee Related
- 1995-06-03 AU AU27368/95A patent/AU2736895A/en not_active Abandoned
- 1995-06-03 HU HU9700060A patent/HUT76827A/hu unknown
- 1995-06-03 CZ CZ9782A patent/CZ8297A3/cs unknown
- 1995-06-27 HR HRP4424714.1A patent/HRP950363A2/xx not_active Application Discontinuation
- 1995-07-06 YU YU45395A patent/YU45395A/sh unknown
- 1995-07-11 PE PE1995273520A patent/PE35196A1/es not_active Application Discontinuation
- 1995-07-12 CO CO95030620A patent/CO4410185A1/es unknown
- 1995-07-12 IL IL11457295A patent/IL114572A0/xx unknown
- 1995-07-12 ZA ZA955781A patent/ZA955781B/xx unknown
-
1997
- 1997-01-04 BG BG101104A patent/BG101104A/xx unknown
- 1997-01-10 NO NO970123A patent/NO970123L/no unknown
- 1997-01-10 FI FI970095A patent/FI970095A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9508395A (pt) | 1997-12-23 |
CZ8297A3 (en) | 1997-09-17 |
CO4410185A1 (es) | 1997-01-09 |
NO970123D0 (no) | 1997-01-10 |
WO1996002496A1 (fr) | 1996-02-01 |
PE35196A1 (es) | 1996-09-05 |
NO970123L (no) | 1997-01-10 |
FI970095A (fi) | 1997-01-10 |
US5686496A (en) | 1997-11-11 |
ZA955781B (en) | 1996-02-22 |
SK1897A3 (en) | 1997-08-06 |
CA2194886A1 (fr) | 1996-02-01 |
HUT76827A (en) | 1997-11-28 |
IL114572A0 (en) | 1995-11-27 |
YU45395A (sh) | 1997-12-05 |
BG101104A (en) | 1998-04-30 |
HU9700060D0 (en) | 1997-02-28 |
DE4424714A1 (de) | 1996-01-18 |
KR970704674A (ko) | 1997-09-06 |
HRP950363A2 (en) | 1997-08-31 |
MX9700245A (es) | 1997-05-31 |
CN1152303A (zh) | 1997-06-18 |
PL318114A1 (en) | 1997-05-12 |
JPH10502646A (ja) | 1998-03-10 |
AU2736895A (en) | 1996-02-16 |
EE9700065A (et) | 1997-08-15 |
EP0770058A1 (fr) | 1997-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961219A0 (fi) | Kemialliset yhdisteet, niiden valmistus ja käyttö | |
FI964395A0 (fi) | Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
FI943570A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita | |
FI955913A0 (fi) | Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
FI963283A (fi) | 4-asemasta heterosyklyylillä substituoituja kinatsoliinijohdannaisia, menetelmiä niiden valmistamiseksi ja niiden käyttö syöpälääkkeinä | |
EE200000468A (et) | Ühendid, nende kasutamine ja farmatseutiline kompositsioon | |
FI973039A0 (fi) | Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia | |
FI860559A0 (fi) | 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
EE9700044A (et) | Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid. | |
EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
NO20006138L (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
ATE240315T1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
DE3679920D1 (de) | Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel. | |
FI970095A (fi) | Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena | |
FI971523A0 (fi) | Bentsopyraani- ja bentsofuusioituja yhdisteitä, niiden valmistus ja käyttö leukotrieeni B4':n (LTB4) antagonisteina | |
EE03690B1 (et) | Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine | |
FI964900A (fi) | Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
AR002978A1 (es) | Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos. | |
FI942468A (fi) | Kemialliset yhdisteet, niiden valmistus ja käyttö | |
FI972965A (fi) | Uusia peptidejä, niiden valmistus ja käyttö | |
NO973486D0 (no) | Substituerte indanylidinacetylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikamenter eller diagnostikum og medikamenter inneholdende forbindelsene | |
FI965172A0 (fi) | Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö | |
FI954026A (fi) | Uudet tetrahydropyraaniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |